Snapshot img

Cardiovascular Medical Devices Market Size 2025-2029

The cardiovascular medical devices market size is forecast to increase by USD 21.71 billion at a CAGR of 7.6% between 2024 and 2029.

The market is driven by the escalating incidence of cardiovascular diseases and the expansion of insurance providers' coverage for related treatments. Market players are responding with innovative business strategies, including product development and strategic collaborations, to capitalize on these opportunities. However, the high cost of cardiovascular procedures poses a significant challenge for both patients and providers, potentially limiting market growth. Artificial intelligence and wireless technologies, such as Al-based electrocardiograms, implantable loop recorders, and event monitors, are also gaining popularity for their ability to improve diagnostic accuracy and patient care.
Effective cost management and continuous innovation will be essential for market success. As the population ages and cardiovascular diseases become increasingly prevalent, companies must navigate this financial obstacle while maintaining quality and affordability to meet patient needs and remain competitive. Companies in this market are focusing on innovative technologies like Al and machine learning based electrocardiogram (ECG) technology to improve the accuracy and efficiency of cardiovascular diagnosis.

What will be the Size of the Cardiovascular Medical Devices Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The Cardiovascular Devices Market encompasses diagnostic monitoring devices, surgical devices, and cardiology devices used to prevent and manage heart disorders, including cardiomyopathy, heart failure, stroke, and heart-related mortality. According to the World Health Organization, cardiovascular diseases are the leading cause of death worldwide, making this market crucial for addressing healthcare resources and improving patient outcomes. Emerging nations are increasingly investing in advanced cardiovascular devices, such as AI-based ECG technology and minimally invasive procedures, to reduce fatal conditions like heart failure and stroke. The market is witnessing significant trends, including the integration of artificial intelligence in diagnostics and the development of more sophisticated surgical devices, such as coronary artery stents.

Cardiovascular Diseases, including heart disorders and heart-related mortality, are major health concerns, and the demand for diagnostic monitoring devices, such as Holter monitors, is on the rise. The market's growth is driven by the need for early detection and effective management of cardiovascular conditions, as well as advancements in technology, such as minimally invasive procedures and AI-based electrocardiogram technology. The Cardiovascular Devices Market is expected to continue growing, as healthcare systems in both developed and emerging nations seek to improve patient care and reduce the burden of cardiovascular diseases. With advancements in technology and a growing focus on preventative care, the market is poised for continued growth and innovation.

How is this Cardiovascular Medical Devices Industry segmented?

The cardiovascular medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  Diagnostic systems
  Surgical devices


Disease Type

  Coronary artery disease
  Arrhythmia
  Heart failure
  Structural heart disease
  Others


End-user

  Hospitals
  ASCs
  Specialty clinics
  Home healthcare settings
  Rehabilitation centers


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW)

By Product Insights

The Diagnostic systems segment is estimated to witness significant growth during the forecast period. The market encompasses a vast array of technologies and devices designed to diagnose, monitor, and treat heart disorders and diseases. This market includes innovative solutions such as AI-based electrocardiogram (ECG) technology, implantable loop recorders, cardiac CT scans, and minimally invasive procedures for detecting clogged arteries and assessing heart function. Valves, pacemakers, stents, Holter monitors, and electrosurgical procedures are among the essential cardiovascular devices used for treating various heart conditions. The World Health Organization reports that cardiovascular diseases (CVDs) are the leading cause of heart-related mortality worldwide. Fatal conditions like atrial fibrillation, stroke, and heart attacks n

Europe Cardiovascular Surgical Devices market USD 762.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.3% from 2024 to 2031. Aging population, high prevalence of cardiovascular diseases, and advanced healthcare infrastructure is expected to aid the sales to USD 937.4 million by 2031

The Europe Cardiac Rhythm Management Devices Market report segments the industry into By Product (Defibrillators, Pacemakers, Cardiac Resynchronization Therapy Devices) and By Geography (Germany, United Kingdom, France, Italy, Spain, Rest of Europe). Get five years of historical data and market forecasts.

According to Cognitive Market Research, the Cardiovascular Devices Market Size was USD XX Billion in 2024 and is set to achieve a market size of USD XX Billion by the end of 2033 growing at a CAGR of XX% from 2025 to 2033.

North America held largest share of XX% in the year 2024 
Europe held share of XX% in the year 2024 
Asia-Pacific held significant share of XX% in the year 2024 
South America held significant share of XX% in the year 2024
Middle East and Africa held significant share of XX% in the year 2024 

Market Dynamics of the Cardiovascular Devices Market

Key Drivers for the Cardiovascular Devices Market

Rising in cardiovascular diseases prevalence fuels the cardiovascular devices market

The cardiovascular disorders are the group of medical condition where it affects heart and blood vessels, encompassing various diseases and disorder that affects on the circulatory system. The cardiac devices help to maintain the regular heart function and blood flow in patients with weak improper function of heart. The global cardiac device market shows significant growth, largely driven by increase in prevalence of heart disease. The cardiovascular disease treatment is costly in terms of healthcare services. Now the conditions like coronary artery disease and heart failure are becoming increasingly prevalent, so there is increase in demand of coronary stents and crucial devices which are used to treat the cardiovascular diseases. Also, the global population increases and continues to age the incidence of chronic heart condition is expected to rise. This demographic condition is shift further and results in growing need of cardiovascular devices that can treat the wide range of heart diseases.

For instance, according to centers for disease control and prevention (CDC) in the United States heart diseases is the major cause of death for both men and women and people of most racial and ethnic groups. They said that one person dies every 33 seconds from cardiovascular disease. In 2022, 702,880 people died from heart disease. That is equivalent to 1 in every 5 deaths

(Source -https://www.cdc.gov/heart-disease/index.html)

Thus, due to the rising patients in cardiovascular disease segment and the advancement in technology boosts the cardiovascular devices market. Rising awareness of health also helps to drive this market.

The rise in healthcare expenditure drives the Cardiovascular Devices Market

Globally the health awareness is increasing vastly countries monitor their health of the population related to cardiac health preferably. They also focus on the expansion of healthcare expenditure where the people also now get aware about their health. The advancement in technology of medical devices increases the patient convenience and now they can get treatment and monitor their health more effectively. Each country now spends on their healthcare expenditure to provide healthcare service to all needy people who cannot afford the costly devices. For instance, U.S. health expenditure grew by 4.1% in 2022 to $4.5 trillion or $13,493 per capita. This rate of growth is similar to pre-pandemic levels (4.1% in 2019). While government expenditure to contain the pandemic resulted in significant growth in NHE, these expenditures fell sharply in 2021 while use of medical goods and services recovered. By 2022, overall trends in health expenditure more closely approximated that of the pre-pandemic era.

(Source - https://www.ama-assn.org/about/research/trends-health-care-spending)

The market for cardiovascular devices is expected to grow as a result of rising healthcare costs. The total amount spent on healthcare-related services, goods, and activities over a given time period usually at the individual, community, national, or international level is referred to as healthcare expenditures. Adoption of cutting-edge cardiovascular technologies and devices is made possible by increased healthcare spending, which improves patient outcomes and care. For Instance, in Europe the spending on cardiovascular disease is greater than the spending done in Germany. CVD is estimated to cost the EU €282 billion annually, with health and long-term care accounting for €155 billion (55%), equaling 11% of EU-health expenditure. Productivity losses accounted for 17% (€48 billion), whereas informal care costs were €79 billion (28%). CVD ...

The global cardiovascular medical devices market is experiencing robust growth, driven by an aging population, rising prevalence of cardiovascular diseases (CVDs), and technological advancements leading to improved diagnostic and therapeutic options. The market, estimated at $50 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 6% from 2025 to 2033, reaching an estimated value of approximately $80 billion by 2033. Key growth drivers include increasing investments in healthcare infrastructure, particularly in emerging economies, expanding access to minimally invasive procedures, and the development of innovative devices such as advanced cardiac rhythm management systems and sophisticated interventional cardiac devices. The market is segmented by application (hospitals, clinics, and others) and device type (cardiac rhythm management devices, interventional cardiac devices, cardiac prosthetic devices, and others). Hospitals currently represent the largest segment due to the complex nature of cardiovascular procedures and the availability of advanced medical infrastructure. However, the clinics segment is expected to witness significant growth driven by the increasing preference for outpatient procedures. Major players like Medtronic, Abbott, Boston Scientific, and Edwards Lifesciences dominate the market, leveraging their strong research and development capabilities, extensive distribution networks, and established brand reputations. However, increasing competition from emerging market players and the potential for consolidation within the industry will continue to shape the market landscape. While technological advancements represent a significant driver, regulatory hurdles, high device costs, and potential reimbursement challenges pose restraints to market growth. Regional variations exist, with North America and Europe currently holding the largest market shares, reflecting higher healthcare expenditure and technological advancements. However, significant growth is anticipated in Asia Pacific, driven by rising healthcare awareness, economic development, and an expanding middle class. The ongoing focus on improving patient outcomes and reducing healthcare costs will be crucial factors determining the future trajectory of the cardiovascular medical devices market.

The global cardiovascular devices market, valued at $58.89 billion in 2025, is projected to experience robust growth, driven by several key factors. The aging global population, increasing prevalence of cardiovascular diseases (CVDs) like coronary artery disease, heart failure, and arrhythmias, are significantly boosting demand for diagnostic, therapeutic, and surgical devices. Technological advancements, such as minimally invasive procedures, sophisticated implantable devices (pacemakers, ICDs), and advanced imaging techniques, are improving treatment outcomes and patient quality of life, fueling market expansion. Furthermore, the rising adoption of remote patient monitoring (RPM) systems allows for better post-operative care and disease management, contributing to market growth. The market is segmented into diagnostic and monitoring devices (ECG, remote cardiac monitoring) and therapeutic and surgical devices (cardiac assist devices, stents, heart valves). Diagnostic and monitoring devices are expected to maintain a significant market share due to the increasing need for early and accurate diagnosis of CVDs. Key players like Abbott, Boston Scientific, Medtronic, and Edwards Lifesciences are actively engaged in research and development, launching innovative products and expanding their market presence through strategic acquisitions and partnerships. Growth is expected to be geographically diverse, with North America and Europe maintaining significant market share due to established healthcare infrastructure and higher healthcare spending. However, rapidly developing economies in Asia Pacific and the Middle East & Africa present significant growth opportunities. The compound annual growth rate (CAGR) of 4.97% from 2025 to 2033 suggests substantial market expansion. However, certain restraints exist. High costs associated with advanced devices, stringent regulatory approvals, and potential reimbursement challenges in certain regions could somewhat limit market growth. Nonetheless, the increasing awareness of CVDs, coupled with government initiatives aimed at improving cardiovascular healthcare infrastructure, are expected to outweigh these challenges. The competitive landscape is highly consolidated, with leading companies focusing on innovation, expansion into emerging markets, and strategic collaborations to maintain their competitive edge. The market's future trajectory is positive, with substantial growth expected across all segments and regions throughout the forecast period. Recent developments include: October 2022: Medtronic plc received United States FDA approval for expanded labeling of a cardiac lead that taps into the heart's natural electrical system, giving patients needed therapy while avoiding complications sometimes associated with traditional pacing methods, such as cardiomyopathy., October 2022 : Biosense Webster, Inc., part of Johnson & Johnson MedTech launched the HELIOSTAR Balloon Ablation Catheter in Europe. The HELIOSTAR Balloon Ablation Catheter is indicated for use in the catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria and, when used with a compatible multi-channel RF generator, for cardiac ablation.. Key drivers for this market are: Rapid Technological Advancements, Increasing Burden of Cardiovascular Diseases; Increased Preference for Minimally Invasive Procedures. Potential restraints include: Rapid Technological Advancements, Increasing Burden of Cardiovascular Diseases; Increased Preference for Minimally Invasive Procedures. Notable trends are: The Electrocardiogram (ECG) Under Diagnostic and Monitoring Devices Segment is Expected to Hold a Significant Share in the Market.

In Europe Cardiovascular Medical Devices Market, Medtronic: The Micra Transcatheter Pacing System, the smallest pacemaker in the world, was introduced by Medtronic.

The Europe Cardiac Monitoring Market Report Segments the Industry Into Device Type (ECG Monitor, Event Recorder and More), B Technology (Conventional (Wired), Wireless & Wearable and More) End-Users (Hospitals & Clinics, Ambulatory Surgical Centers and More), and Country (Germany, United Kingdom, France, Italy, Spain, Rest of Europe). The Market Forecasts are Provided in Terms of Value (USD).

The global integrated cardiology devices market is experiencing robust growth, driven by the increasing prevalence of cardiovascular diseases, technological advancements leading to minimally invasive procedures, and a rising geriatric population. The market, valued at approximately $15 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 7% from 2025 to 2033, reaching an estimated market value of $25 billion by 2033. This growth is fueled by factors such as the increasing adoption of sophisticated diagnostic and therapeutic devices, improved patient outcomes, and the growing preference for less invasive surgical procedures. Furthermore, the rising demand for remote patient monitoring systems and the increasing integration of AI and machine learning in cardiology are further accelerating market expansion. However, the market faces certain challenges. High costs associated with advanced devices and procedures may limit accessibility in developing regions. Stringent regulatory approvals and reimbursement policies can also pose hurdles for market penetration. Despite these restraints, the continued innovation in device technology and the growing awareness of cardiovascular health among the population are poised to drive significant market growth in the coming years. Key players like Medtronic, Boston Scientific, and Abbott Laboratories are actively investing in research and development, further fueling competition and technological advancements within the sector. Regional growth will be particularly strong in North America and Europe, reflecting the high prevalence of cardiovascular disease and robust healthcare infrastructure in these areas.

The global cardiac medical devices market is experiencing robust growth, driven by an aging population, rising prevalence of cardiovascular diseases, technological advancements leading to minimally invasive procedures, and increasing healthcare expenditure. The market's expansion is fueled by innovations in implantable cardioverter-defibrillators (ICDs), pacemakers, cardiac rhythm management (CRM) devices, and minimally invasive cardiac surgery tools. Demand for advanced diagnostic imaging technologies like echocardiography and cardiac CT scans also contributes to market growth. While regional variations exist, North America and Europe currently hold significant market share due to established healthcare infrastructure and high adoption rates of advanced medical technologies. However, the Asia-Pacific region is projected to witness the fastest growth in the coming years, driven by rising disposable incomes, improving healthcare access, and increasing awareness of cardiovascular health. Growth is also influenced by factors like favorable reimbursement policies and government initiatives promoting preventative healthcare. Competition among established players like Medtronic, St. Jude Medical, Boston Scientific, and LivaNova, along with emerging market entrants, is intensifying, leading to increased innovation and improved device affordability. Challenges include stringent regulatory approvals, high device costs, and the potential for complications associated with implanted devices. Nevertheless, the long-term outlook for the cardiac medical devices market remains positive, with continuous growth predicted throughout the forecast period. The market segmentation reveals significant opportunities within specific device types and applications. For instance, the demand for advanced pacemakers and ICDs with remote monitoring capabilities is increasing, while the growth of minimally invasive procedures is driving demand for smaller, more sophisticated surgical tools. Furthermore, technological advancements are leading to improved device longevity and reduced complications, thus positively impacting market growth. The continued focus on improving patient outcomes and reducing healthcare costs through better device technology and efficient treatment protocols are key driving forces. While certain regions show faster growth than others, the overall market is poised for substantial expansion, presenting considerable investment potential for stakeholders across the value chain. The continued rise in cardiovascular diseases worldwide will necessitate a constant stream of technological innovations and improved access to advanced cardiac care, further driving market expansion.

The Cardiac Assist Devices Market is estimated to be worth USD 1.4 Billion in 2025 and is expected to grow to USD 2.5 Billion by 2035, with a CAGR of 5.8% during the forecast period.

Country-wise Analysis

Competitive Outlook

Cardiovascular Medical Devices Market Outlook

The global cardiovascular medical devices market size was valued at approximately USD 50 billion in 2023, and it is forecasted to reach around USD 85 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period. The market's robust growth can be attributed to the rising incidence of cardiovascular diseases (CVDs), advancements in medical technology, and increasing awareness regarding early diagnosis and preventive healthcare.

The rising prevalence of cardiovascular diseases is a major growth factor for the cardiovascular medical devices market. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, resulting in an estimated 17.9 million deaths each year. This escalating number has led to an increased demand for effective diagnostic and therapeutic solutions, thus driving the market for cardiovascular medical devices. The aging global population also plays a significant role, as older adults are more susceptible to CVDs, necessitating the use of advanced medical devices for effective management and treatment.

Technological advancements in the field of medical devices are another significant growth driver. Innovations such as minimally invasive surgical techniques, the development of bioresorbable stents, and the integration of artificial intelligence (AI) and machine learning in diagnostics have revolutionized cardiovascular care. These technological advancements not only enhance the efficacy and safety of treatments but also reduce recovery times and improve patient outcomes, thereby fueling market growth. Moreover, the increasing adoption of wearable devices and remote monitoring systems is enabling continuous and real-time monitoring of patients with cardiovascular conditions, further augmenting the demand for advanced medical devices.

Government initiatives and favorable reimbursement policies are also contributing to the growth of the cardiovascular medical devices market. Many governments are investing in healthcare infrastructure and promoting the use of advanced medical technologies to combat the rising burden of cardiovascular diseases. Additionally, favorable reimbursement policies and health insurance schemes are making cardiovascular treatments more accessible and affordable, thereby encouraging more patients to opt for advanced medical interventions. These factors collectively are expected to propel the market's growth in the coming years.

Regionally, North America dominates the cardiovascular medical devices market, followed by Europe and the Asia Pacific. The high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and the presence of major medical device companies are key factors driving the market in North America. Europe also holds a significant market share due to the increasing incidence of cardiovascular diseases and the availability of advanced medical technologies. The Asia Pacific region is expected to witness the highest growth rate during the forecast period, driven by improving healthcare infrastructure, rising healthcare expenditure, and increasing awareness about cardiovascular health.

Product Type Analysis

The cardiovascular medical devices market can be segmented by product type into diagnostic and monitoring devices, surgical devices, and interventional devices. Diagnostic and monitoring devices include electrocardiogram (ECG) machines, Holter monitors, and event monitors, which are essential for the accurate diagnosis and continuous monitoring of cardiovascular conditions. The demand for these devices is driven by the increasing incidence of CVDs and the growing emphasis on early diagnosis and preventive healthcare. Technological advancements, such as the development of portable and wearable ECG monitors, are further enhancing the market's growth by providing real-time monitoring and improving patient compliance.

Surgical devices are another critical segment in the cardiovascular medical devices market. This category includes heart valves, grafts, and cannulas used in various cardiovascular surgeries such as heart valve replacement, coronary artery bypass grafting (CABG), and others. The rising number of cardiovascular surgeries, driven by the high prevalence of heart diseases and the increasing geriatric population, is boosting the demand for surgical devices. Additionally, advancements in surgical techniques, such as minimally invasive surgeries and robotic-assisted surgeries, are improving patient outcomes and reducing recovery times, thereby

Cardiovascular Devices Market Outlook

According to our latest research, the global cardiovascular devices market size reached USD 62.8 billion in 2024, reflecting robust demand and technological advancements in the sector. The market is projected to grow at a compelling CAGR of 7.2% from 2025 to 2033, with the total market value forecasted to reach USD 116.7 billion by 2033. The key growth driver for the cardiovascular devices market is the rising prevalence of cardiovascular diseases worldwide, coupled with ongoing innovations in minimally invasive procedures and diagnostic technologies.

The primary growth factor in the cardiovascular devices market is the increasing global burden of cardiovascular diseases (CVDs), which remain the leading cause of death worldwide. Sedentary lifestyles, unhealthy dietary habits, and the rising incidence of obesity and diabetes have all contributed to a surge in heart-related ailments. This has created an urgent need for advanced diagnostic and therapeutic interventions, driving significant investments in the research and development of next-generation cardiovascular devices. Furthermore, awareness campaigns by health organizations and governments have led to earlier diagnosis and intervention, further fueling the demand for innovative devices across both developed and developing economies.

Another crucial factor propelling the cardiovascular devices market is the rapid technological progress in device design, material science, and digital health integration. The emergence of minimally invasive surgical techniques, such as transcatheter aortic valve replacement and advanced stenting procedures, has revolutionized patient outcomes by reducing recovery times and minimizing complications. Additionally, the integration of artificial intelligence and machine learning into diagnostic devices has enhanced the accuracy and efficiency of cardiac monitoring, making early detection and personalized treatment more accessible. These technological advancements are not only improving patient care but also expanding the market by attracting a broader patient population, including those previously deemed high-risk for traditional surgical interventions.

Favorable reimbursement policies and increased healthcare expenditure in both public and private sectors are also significant contributors to the market’s growth. Governments and insurance providers are recognizing the long-term cost benefits of early and effective intervention in cardiovascular diseases, leading to improved coverage for advanced procedures and devices. This, in turn, is encouraging healthcare providers to adopt cutting-edge cardiovascular technologies. Moreover, the expansion of healthcare infrastructure in emerging markets is creating new avenues for market players, as more patients gain access to sophisticated diagnostic and therapeutic solutions. Collectively, these factors are fostering a conducive environment for sustained market expansion.

From a regional perspective, North America continues to dominate the cardiovascular devices market, accounting for the largest revenue share in 2024, due to its advanced healthcare infrastructure, high adoption rate of innovative technologies, and substantial investment in research and development. However, the Asia Pacific region is emerging as a highly lucrative market, driven by a rapidly aging population, increasing healthcare expenditure, and growing awareness of cardiovascular health. Europe also holds a significant share, supported by strong government initiatives and a well-established healthcare system. Meanwhile, Latin America and the Middle East & Africa are expected to witness steady growth, propelled by improving healthcare access and rising incidence of cardiovascular diseases.

Product Type Analysis

The cardiovascular devices market is broadly segmented by product type into diagnostic and monitoring devices, as well as therapeutic and surgical devices. Diagnostic and monitoring devices, which include electrocardiographs (ECGs), Holter monitors, event monitors, and

The Europe Cardiac Rhythm Management Devices Market size was valued at USD 4779.45 Million in 2024 and is projected to reach USD 7739.29 Million by 2032, growing at a CAGR of 6.21% from 2026 to 2032.

Key Market Drivers

• Increasing Prevalence of Cardiovascular Diseases: The increasing prevalence of cardiovascular illnesses in the European population is a major driver of cardiac rhythm management devices. According to the European Heart Network’s 2022 report, cardiovascular illnesses are still the largest cause of mortality in Europe, accounting for 35% of all fatalities, with an estimated 13 million new instances of cardiovascular disease diagnosed each year. Because of this high illness burden, advanced cardiac rhythm management technologies are critical for improving patient monitoring, diagnosis, and therapy.

• Aging Population: The aging population in Europe is considerably contributing to the expansion of the cardiac rhythm management device market. Eurostat data from 2021 show that 20.8% of the European population is already 65 or older, with estimates indicating that this figure will rise to 29.5% by 2050.

Europe Cardiac Assist Devices Market valued at USD 600 million, driven by rising cardiovascular diseases, tech advancements, and aging population. Key segments include VADs and hospitals.

In Europe Cardiovascular Medical Device Market, was valued at approximately USD 10.11 billion in 2022 and is projected to reach USD 12.45 billion by 2029, registering a Compound Annual Growth Rate (CAGR) of 8.65% during the forecast period.

The Europe Cardiac Arrhythmia Monitoring Devices Market report segments the industry into Devices (Event Monitoring Devices, Continuous Rhythm Monitoring Devices, Holter Monitoring Devices, Other Devices), Service Providers (Mobile Cardiac Telemetry Monitoring Service Providers, Independent Diagnostic Testing Facilities/Clinics), and Geography (Germany, United Kingdom, France, Italy, Spain, Rest of Europe).

The size of the Europe Cardiac Rhythm Management Devices Market market was valued at USD 6.2 Billion in 2023 and is projected to reach USD 8.44 Billion by 2032, with an expected CAGR of 4.50% during the forecast period. The Europe Cardiac Rhythm Management (CRM) Devices Market is therefore a medical device industry that focuses on diagnosis as well as treatment of abnormal heart rate and other cardiac disorders. Major products in this market include pacemaker, Implantable Cardioverter-Defibrillators (ICDs), Cardiac Resynchronization Therapy (CRT) devices and external Defibrillators. Current developments in the industry include; Technology on medical devices like leadless manners, and innovative methods on distant monitoring of patients with pacemakers; Personalized and invasive approaches to the treatments. It is caused by the higher incidence of arrhythmias and heart failure, the wearer’s aging, and new achievements in the CRM market contributing to the enhanced functions of brands. Moreover, favorable measures in the sphere of healthcare, further investigations, as well as the appearance of innovative therapeutic products give a positive impact on the market. The focus on increasing patient’s quality of life and on increasing availability of innovative cardiac treatment also contributes to the market growth in Europe. Recent developments include: November 2022: Heart experts at University Hospital Southampton (UHS) implanted a new leadless pacemaker defibrillator system to treat patients at risk of sudden cardiac arrest. The surgery is a component of a global clinical trial involving the implantation of the innovative leadless pacemaker EMPOWER and the subcutaneously implanted cardioverter-defibrillator (S-ICD)., February 2022: Abbott reported the patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i pivotal clinical study. The implant of Abbott's investigational Aveir dual-chamber leadless pacemaker represents a significant technological milestone for leadless pacing technology. The study aims to enroll up to 550 patients from up to 80 sites, including Europe, and after receiving an implant, every patient is likely to be monitored for at least 12 months.. Key drivers for this market are: Increasing Prevalence of Cardiovascular Disorders, Technological Advancements; Rise in the Use of Ambulatory and Home Services for Cardiac Monitoring. Potential restraints include: High Cost of Devices. Notable trends are: External Defibrillator (ED) Segment is Expected to Hold a Significant Share During the Forecast Period.

The Europe Cardiac Assist Devices Market is Segmented by Product (Intra-aortic Balloon Pump, Total Artificial Heart, and Ventricular Assist Device), and Geography (Germany, UK, France, Italy, Spain, and Rest of Europe). The report offers the value (in USD million) for the above segments.